Angioplasty Balloons Market By Product Type (Normal Ballons, Cutting Ballons, Drug-Eluting Ballons), Application (Coronary Angioplasty, Peripheral Angioplasty), End-Users (Hospitals, Ambulatory Surgical Centers, Catheterization Laboratories), & Region for 2024-2031

Angioplasty Balloons Market Valuation – 2024-2031

The increasing geriatric population and cardiovascular diseases (CVDs) are becoming more prevalent among the elderly due to age-related factors such as diminished blood channel flexibility and increasing plaque formation. For instance, according to the geriatric population in 2022 globally was estimated to be 1.4 billion. This demographic shift towards an older population has increased demand for minimally invasive procedures and angioplasty balloons. Thus, the increasing geriatric population is driving the market size to surpass USD 2.05 Billion in 2024 to reach a valuation of around USD 2.62 Billion by 2031.

Increasing public awareness of cardiovascular diseases (CVDs) and the availability of minimally invasive treatment alternatives, such as angioplasty, are key factors propelling the industry’s growth. As more people become aware of the dangers and symptoms associated with CVDs, there is a greater emphasis on obtaining prompt medical assistance for diagnosis and treatment. The increasing awareness of CVD and minimally invasive procedures is enabling the market to grow at a CAGR of 3.43% from 2024 to 2031.

Angioplasty Balloons MarketDefinition/ Overview

Angioplasty balloons are small, inflatable medical devices utilized in a minimally invasive procedure known as angioplasty, aimed at widening narrowed or blocked arteries. The Balloon Angioplasty with the Distal Protection of Stent Retriever (BASIS) technique is a revolutionary thrombectomy approach that allows for emergent balloon angioplasty via the retrieval stent’s wire. Balloon angioplasty is performed, in some clinical scenarios of stent implantation retrieval stent placement, passage of aspiration catheter following after balloon deflated, retrieval stent re-placement, and withdrawal of the retrieval stent, balloon angioplasty via wire of retrieval stent, negative aspiration, and revascularization.

Angioplasty balloons are revolutionizing cardiovascular care by providing a minimally invasive alternative to obstructed arteries. These small miracles, placed through a catheter, expand within the obstruction, expanding the route and restoring blood flow. When compared to traditional open-heart surgery, angioplasty has substantial advantages, including shorter recovery times, less pain, and a lower chance of complications. This patient-friendly approach, combined with advances in balloon technology such as drug-eluting and cutting variations, expands therapy possibilities for a variety of arterial blockages. The rise of angioplasty balloons is being driven by an alarming increase in cardiovascular illnesses and a growing preference for minimally invasive procedures.

As technology advances, angioplasty balloons will undoubtedly remain a game changer in interventional cardiology, promising a brighter future for cardiovascular health on a worldwide scale. After balloon angioplasty of the stenotic location, the risk of aspiration catheters passing through the occlusion site increases. Balloon angioplasty should be performed with caution if the stenotic lesion covers the perforators of the penetrating artery, such as the lenticulostriate or pontine perforating arteries.

How the Increasing Prevalence of Cardiovascular Diseases is Driving the Growth of Angioplasty Balloons Market?

The increasing prevalence of cardiovascular diseases is fueling the demand for the angioplasty balloons market. A burgeoning population faces increased risks of cardiovascular diseases (CVDs) due to factors such as poor lifestyles, aging populations, and rising diabetes rates. For instance, according to the report, in the United States in 2021, around 695,000 people died due to heat disease and every 33 seconds one patient died due to CVD. This demographic trend highlights a growing desire for minimally invasive procedures such as angioplasty, in which balloons are critical tools for expanding clogged arteries.

The prevalence of unhealthy lifestyles, such as sedentary habits, poor dietary choices, and tobacco use, contributes considerably to the rising incidence of CVD worldwide. In addition, as the population ages, the prevalence of age-related risk factors such as hypertension and atherosclerosis increases, adding to the burden of CVDs. Furthermore, the rising incidence of diabetes, particularly type 2 diabetes, heightens the risk of cardiovascular problems, demanding prompt measures to avoid negative outcomes.

Evolving healthcare problems, minimally invasive procedures such as angioplasty have emerged as favored treatment options. Angioplasty is the process of inserting specialized balloons into restricted or obstructed arteries, which are subsequently inflated to enlarge the arterial lumen and restore proper blood flow. This method has several advantages over standard surgical procedures, including shorter recovery times, a lower risk of complications, and better patient outcomes. Angioplasty has a significant advantage over traditional open-heart surgery since it is a minimally invasive procedure with faster recovery times, less post-procedural discomfort, and a lower risk of complications. This patient-centered approach has resulted in a significant preference for angioplasty operations involving balloons.

Angioplasty using balloons is a less intrusive alternative to standard open-heart surgery, which frequently results in longer hospital stays, lengthy recovery periods, and increased problems. Its minimally invasive nature means less stress to surrounding tissues, which leads to faster recovery times and less post-operative pain for patients. Furthermore, the lower risk of complications associated with angioplasty helps to enhance patient outcomes and satisfaction. This patient-friendly appeal has resulted in an increasing preference for balloon angioplasty among healthcare personnel and patients alike. The procedure’s capacity to provide successful arterial dilation while reducing patient discomfort and recovery time highlights its importance in current cardiovascular care. As a result, angioplasty is becoming a favored treatment choice for a variety of cardiovascular diseases, helping to progress the field of minimally invasive cardiology.

How the Risk of Angioplasty Balloons in the Bypass Surgery is Hampering the Growth of the Angioplasty Balloons Market?

In circumstances where arteries are significantly narrowed or hardened due to calcification, angioplasty balloons alone may not be enough to dilate the vessels adequately. It is critical to understand that angioplasty balloons may not be appropriate for all people or types of blockages. Severe occlusions or complex lesions may provide difficulties during angioplasty, potentially leading to poor results or procedural consequences. As a result, healthcare providers must carefully evaluate the severity and complexity of each patient’s disease to identify the best treatment strategy.

Despite their minimum invasiveness, angioplasty balloons may face competition from even less invasive treatment modalities such as medication management or upcoming technologies that are still in the development stage. The changing landscape of cardiovascular therapy options can have a substantial impact on market dynamics.

While balloon angioplasty has proven effective in expanding restricted arteries and restoring blood flow, the introduction of alternative techniques such as pharmaceutical therapies presents a problem. Medication management techniques, such as the use of antiplatelet medicines, statins, and blood pressure drugs, provide non-invasive ways to control cardiovascular disease. Furthermore, advances in medical technology continue to promote the development of novel treatments, such as drug-coated balloons or bioresorbable stents, intending to further reduce the invasiveness of cardiovascular procedures.

Balloon angioplasty requires well-equipped catheterization laboratories with well-trained Staff. The limited access to such facilities especially in remote areas, poses significant challenges and restricts patients’ access to these lifesaving procedures. Many localities, particularly rural or physically remote areas, may have limited or no access to catheterization labs. Patients in these places may experience difficulties in prompt cardiovascular therapy, such as balloon angioplasty, due to a lack of close facilities.

Category-Wise Acumens

How the Increasing Prevalence of Peripheral Artery Diseases is Driving Demand for Cutting Balloons Segment in the Angioplasty Balloons Market?

The cutting Balloons segment is substantially dominating the angioplasty balloon market. The increased frequency of peripheral artery disease (PAD) and coronary artery disease (CAD) requires effective and minimally invasive therapeutic alternatives. Scoring balloons have significant advantages over typical angioplasty balloons, which is why they are increasingly being used to treat PAD and CAD. These benefits include improved plaque modification, which enables more precise and comprehensive removal of arterial plaque, enhancing artery patency and blood flow. Furthermore, scoring balloons has a lower chance of vascular dissection and recoil than conventional balloons, which leads to better procedural outcomes and lower patient risks.

In addition, advances in scoring balloon technology have improved stent delivery and expansion. Scoring balloons are frequently used in conjunction with drug-eluting stents to optimize stent deployment and ensure appropriate expansion within the treated artery. This collaborative strategy improves the efficacy of stent-based therapies and leads to better long-term results for patients with PAD and CAD. Furthermore, the adoption of specialty goods such as scoring and cutting balloons, as well as significant research and development (R&D) efforts by large companies, are likely to boost demand. Specialty balloons, such as AngioSculpt and Flextome, have been approved for sale in key markets such as the United States, Europe, and Japan. The widespread availability of products in important locations is expected to increase their market share in the next years.

DEBs’ advantages, including as their capacity to administer medication directly to the site of artery illness, resulting in lower restenosis rates and better long-term outcomes, contribute to their increasing appeal among healthcare practitioners and consumers. Furthermore, DEBs’ lower cost compared to stents makes them an appealing option for healthcare organizations aiming to optimize cost-effectiveness while maintaining high-quality care standards.

The coronary angioplasty segment is significantly growing in the angioplasty balloons market. The dismal statistics highlight the critical need for better treatment solutions for coronary artery disease, which is driving the expansion of this category. Coronary artery disease, which is defined by the narrowing or blocking of the coronary arteries that feed blood to the heart muscle, is a major global health concern. Sedentary lifestyles, poor eating habits, and an aging population all contribute to the increasing prevalence of this illness. As a result, there is an increasing demand for therapies to manage coronary artery disease and reduce its negative impact on patients’ health and well-being.

The strong rise of the coronary artery disease segment can be due to a greater emphasis on preventative healthcare, early detection, and enhanced treatment options. Healthcare practitioners are increasingly prioritizing procedures including angioplasty, stenting, and coronary artery bypass surgery to relieve symptoms, enhance heart function, and lower the risk of life-threatening consequences from coronary artery disease.

Gain Access to Angioplasty Balloons Market Report Methodology

Country/Region-wise Acumens

How the Advanced Technology and Presence of Key Players in the Region are Fostering the Growth of North America in the Angioplasty Balloons Market?

The local presence of major industry players is important in fostering market growth. These established companies bring with them experience, resources, and cutting-edge technology that help to develop and advance cardiovascular therapies. In addition, the changes in US FDA policy have a significant impact on the regional cardiovascular intervention industry. Regulatory changes and revisions in FDA regulations can have an impact on the clearance process for medical devices and therapies, as well as the general regulatory landscape. This can influence market dynamics by promoting or impeding the entry of new products and technology, hence altering the competitive environment in the region.

The growing number of percutaneous coronary interventions (PCIs) is a key driver of market growth in the region. PCIs, including procedures such as angioplasty and stent placement, are minimally invasive techniques used to treat coronary artery disease. The increasing prevalence of coronary artery disease and the adoption of PCI procedures as a preferred treatment option contributes to the rising demand for cardiovascular interventions in the region.

How the Increasing Healthcare Investment and Healthcare Infrastructure is Expected to show Growth in the Asia Pacific Angioplasty Balloons Market During the Forecast Period?

Asia Pacific is expected to be the fastest-growing region throughout the forecast period. The cardiovascular intervention market in the region is growing significantly, owing to the rising healthcare spending in the region demonstrates a greater commitment to upgrading healthcare infrastructure and services. This increased investment in healthcare facilities and resources opens the door to breakthroughs in cardiovascular interventions as healthcare providers try to improve patient care and outcomes.

The positive government assistance drives market expansion in the region. Government programs focused on boosting public health and treating cardiovascular illnesses help to drive the development and adoption of new treatments and technology. Policies that prioritize cardiovascular health and direct resources toward preventative measures, early identification, and treatment of heart-related illnesses foster market growth.

Competitive Landscape

The angioplasty balloon market is expected to witness continued growth, driven by the rising prevalence of cardiovascular diseases and the increasing adoption of minimally invasive procedures. Consolidation through mergers and acquisitions might occur as companies strive to strengthen their market positions. Collaboration between established players and emerging companies for technological advancements is also a possibility. The focus will be on developing even more effective, durable, and user-friendly angioplasty balloon solutions to improve patient outcomes and expand access to this life-saving technology.

The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the angioplasty balloon market include

• Medtronic
• Boston Scientific Corporation
• Johnson & Johnson Services, Inc.
• Abbott
• C. R. Bard, Inc.
• Spectranetics
• Terumo Medical Corporation
• Cardinal Health
• BIOTRONIK
• Cook
• ENDOCOR GmbH
• B. Braun Melsungen AG

Angioplasty Balloons Market Latest Developments

• In May 2022, Medtronic announced that the low-profile drug-coated balloon platform received U.S. FDA approval to treat Peripheral Arterial Diseases.
• In March 2021, Medtronic announced the launch of the Chameleon PTA balloon catheter in Germany, Italy, Portugal, South Africa, Spain, and Turkey. The device is suitable for use in native or synthetic arteriovenous dialysis fistulae, as well as femoral, iliac, and renal arteries. The gadget allows for the infusion of diagnostic or therapeutic fluids through an integrated injection point placed near the balloon.
• In July 2021, Medtronic announced the launch of Prevail Drug Coated Balloon Catheter in Europe. The Prevail DCB is utilized during percutaneous coronary intervention (PCI) operations to treat constricted or blocked coronary arteries in CAD patients.
• In March 2024, Boston Scientific Corporation, announced that the AGENT Drug-Coated Balloon received the approval of the U.S. FDA. AGENT Drug-Coated Balloon (DCB) treats coronary in-stent restenosis (ISR) in individuals with coronary artery disease. ISR is defined as the obstruction or narrowing of a stented artery caused by plaque or scar tissue.

Report Scope

Angioplasty Balloons Market, By Category

Product Type

• Normal Ballons
• Cutting Ballons
• Drug-Eluting Balloons

Application

• Coronary Angioplasty
• Peripheral Angioplasty

End-Users

• Hospitals
• Ambulatory Surgical Centers
• Catheterization Laboratories

Region

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any <a href="https//www.marketresearch.com/nee